Legere told CNBC he believes that AT&T is "bleeding" and also claimed also claimed that in five years T-Mobile would surpass AT&T. » Read More
CNBC's Jim Cramer breaks down the fall in oil and how it is affecting the broader markets.
Most analysis sees crude prices rebounding in the back half of 2016, but oil futures faces headwinds in the coming months, experts told CNBC.
U.S. markets appeared to look past another Chinese sell-off Monday, but fourth-quarter earnings forecasts do not bode well, experts told CNBC.
Several factors are being overlooked when discussing drug pricing in the U.S., three pharma CEOs say.
Goldman Sachs Chief Asia Equity Strategist Timothy Moe blames China's market decline on growth, liquidity and policy.
Powerball jackpot reaches a historic $1.3 billion, and David Bowie has died after a battle with cancer, reports CNBC's Sue Herera.
Netflix led among nominations but fails to win, but Amazon walks away with two awards.
Eli Lilly CEO John Lechleiter discusses clinical trials of his company's treatments for Alzheimer's disease.
Eli Lilly's John Lechleiter says he's optimistic about the year ahead for the pharmaceuticals industry, including measures to help patients afford prescription drugs.
CNBC Contributor Joe Lavorgna says employment isn't the best forward indicator; Steve Wood of Russell Investments says investors should look for international investments.
Demand for U.S. dollars in China is rapidly increasing. CNBC's Eunice Yoon explains.
CNBC's Jim Cramer explains why he is watching "the real market," and Freeport-McMoRan.
CNBC's Bob Pisani looks at expected fourth quarter earnings across sectors, and the weak performance of asset managers last week.
CNBC's David Faber reports new funding could value Uber at $62.5 billion, and the funding is being carried out through Morgan Stanley's brokerage high net worth network.
Jim Cramer explains what to watch ahead of the open, including Morgan Stanley's call on Under Armour and VF Corp.
CNBC's Susan Li reports on China's market slide; and CNBC's Jim Cramer, weighs in.
Today's bell ringers are former drug enforcement administrative director and 46th Governor of Arkansas Asa Hutchinson, at the NYSE, and drug developer Oasmia Pharmaceutical executive chairman Julian Aleksov, at the Nasdaq.
Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."
Carl Quintanilla is an Emmy-winning reporter and co-anchor of CNBC's "Squawk on the Street," broadcast live from the NYSE.
“Squawk on the Street” Co-Anchor
Simon Hobbs co-anchors the 10 a.m. hour of CNBC's "Squawk on the Street" live from the New York Stock Exchange.
Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.
Sara Eisen is a correspondent for CNBC, focusing on currencies and the global consumer.